SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'grossprofit2asset'
ICUI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ICUI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ICU Medical's annualized Gross Profit for the quarter that ended in Dec. 2023 was $686 Mil. ICU Medical's average Total Assets over the quarter that ended in Dec. 2023 was $4,378 Mil. Therefore, ICU Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 15.68%.
The historical data trend for ICU Medical's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where ICU Medical's Gross-Profit-to-Asset % falls into.
ICU Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
Gross-Profit-to-Asset % | = | Gross Profit (A: Dec. 2023 ) | / | ( (Total Assets (A: Dec. 2022 ) | + | Total Assets (A: Dec. 2023 )) | / count ) |
= | 739.873 | / | ( (4515.641 | + | 4378.439) | / 2 ) | |
= | 739.873 | / | 4447.04 | ||||
= | 16.64 % |
ICU Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:
Gross-Profit-to-Asset % | = | Gross Profit (Q: Dec. 2023 ) | / | ( (Total Assets (Q: Sep. 2023 ) | + | Total Assets (Q: Dec. 2023 )) | / count ) |
= | 686.34 | / | ( (4376.864 | + | 4378.439) | / 2 ) | |
= | 686.34 | / | 4377.6515 | ||||
= | 15.68 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Thank you for viewing the detailed overview of ICU Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Woolson | officer: VP, GM-Infusion Capital | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Christian B. Voigtlander | officer: Chief Operating Officer | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Vivek Jain | director, officer: Chairman and CEO | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
Virginia Ruth Sanzone | officer: VP, General Counsel | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
George A Lopez | director, officer: Chairman, other: Chairman | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
William Seeger | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Smiths Group International Holdings Ltd | 10 percent owner | C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB |
Group Plc Smiths | 10 percent owner | 765 FINCHKEY ROAD, LONDON X0 00000 |
Kolleen T Kennedy | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Robert S Swinney | director | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Laurie Hernandez | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Brian Michael Bonnell | officer: Chief Financial Officer | ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Scott E Lamb | officer: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Kevin J Mcgrody | other: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
From GuruFocus
By sperokesalga sperokesalga • 04-24-2023
By Value_Insider Value_Insider • 12-19-2022
By Marketwired Marketwired • 10-13-2021
By GuruFocus Research • 11-06-2023
By GuruFocusNews GuruFocusNews • 12-29-2021
By GuruFocusNews GuruFocusNews • 02-04-2022
By sperokesalga sperokesalga • 02-21-2023
By PRNewswire PRNewswire • 02-02-2021
By PRNewswire PRNewswire • 02-08-2023
By GuruFocus Research • 09-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.